Health Care: Drugs

Merck & Co Inc (MRK: NYSE)

$47.75 -0.05 | -0.10%
06/18/13 - 04:00 PM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 47.27B 48.05B 45.99B 27.43B
Cost of Sales 9.47B 9.44B 11.02B 6.44B
Gross Operating Profit 37.80B 38.60B 34.97B 20.99B
Selling, General, and Administrative Expenses 12.78B 13.73B 13.24B 8.54B
Research & Development 8.17B 8.47B 10.99B 5.84B
Operating Income before D & A (EBITDA) 16.86B 16.40B 10.74B 6.60B
Depreciation & Amortization 6.98B 7.43B 7.38B 2.58B
Interest Income 232.00M 199.00M 83.00M 210.20M
Other Income - Net -634.00M -396.00M -672.00M 10.92B
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 9.45B 8.08B 2.37B 15.75B
Interest Expense 714.00M 749.00M 715.00M 458.00M
Pre-Tax Income 8.74B 7.33B 1.65B 15.29B
Income Taxes 2.44B 942.00M 671.00M 2.27B
Minority Interest 131.00M 120.00M 121.00M 122.90M
Net Income From Continuing Operations 6.30B 6.39B 982.00M 13.02B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 6.30B 6.39B 982.00M 13.02B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 6.17B 6.27B 861.00M 12.90B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 6.96B 7.70B 1.97B 14.66B
Preferred Dividends
Net Income Available To Common 6.30B 6.38B 980.00M 13.02B
Basic EPS from Continuing Ops. 2.03 2.04 0.28 5.67
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.03 2.04 0.28 5.67
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 2.03 2.04 0.28 5.67
Basic Normalized Net Income/Share 2.24 2.46 0.56 6.38
EPS fr Continuing Ops. 2.00 2.02 0.28 5.65
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 2.00 2.02 0.28 5.65
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 2.00 2.02 0.28 5.65
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 2.21 2.43 0.56 6.36
Dividends Paid per Share 1.69 1.56 1.52 1.52

Portfolios with MRK

View All

Latest MRK Headlines from TheStreet

More Financial News for MRK

Press Releases for MRK

See All Press Releases

Partner Headlines for MRK

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter